Alps Advisors Inc Longeveron Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$5.93 - $15.61 $116,554 - $306,814
-19,655 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$5.06 - $13.8 $12,493 - $34,072
-2,469 Reduced 11.16%
19,655 $271,000
Q4 2021

Feb 09, 2022
BUY
$2.92 - $42.3 $64,602 - $935,845
22,124 New
22,124 $267,000

Others Institutions Holding LGVN

# of Institutions
2
Shares Held
1.18K
Call Options Held
0
Put Options Held
0
View Full List

About Longeveron Inc.

LGVN Quotes by TradingView
  • Ticker LGVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,925,940
  • Market Cap $10.8M
  • Description
  • Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...
More about LGVN
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email